nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Neutropenic sepsis—Dactinomycin—ocular cancer	0.076	0.182	CcSEcCtD
Trabectedin—Extravasation—Carboplatin—ocular cancer	0.0407	0.0974	CcSEcCtD
Trabectedin—Multi-organ failure—Dactinomycin—ocular cancer	0.0404	0.0968	CcSEcCtD
Trabectedin—Febrile neutropenia—Dactinomycin—ocular cancer	0.0219	0.0524	CcSEcCtD
Trabectedin—Hepatomegaly—Dactinomycin—ocular cancer	0.0186	0.0446	CcSEcCtD
Trabectedin—Hepatotoxicity—Dactinomycin—ocular cancer	0.0171	0.0408	CcSEcCtD
Trabectedin—Necrosis—Dactinomycin—ocular cancer	0.0168	0.0402	CcSEcCtD
Trabectedin—Extravasation—Dactinomycin—ocular cancer	0.0151	0.0362	CcSEcCtD
Trabectedin—Infection—Carboplatin—ocular cancer	0.0126	0.0301	CcSEcCtD
Trabectedin—Sepsis—Dactinomycin—ocular cancer	0.0114	0.0274	CcSEcCtD
Trabectedin—Hepatic failure—Dactinomycin—ocular cancer	0.0106	0.0255	CcSEcCtD
Trabectedin—Body temperature increased—Carboplatin—ocular cancer	0.01	0.024	CcSEcCtD
Trabectedin—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.00861	0.0206	CcSEcCtD
Trabectedin—Pancytopenia—Dactinomycin—ocular cancer	0.00785	0.0188	CcSEcCtD
Trabectedin—Neutropenia—Dactinomycin—ocular cancer	0.00773	0.0185	CcSEcCtD
Trabectedin—Stomatitis—Dactinomycin—ocular cancer	0.00718	0.0172	CcSEcCtD
Trabectedin—Agranulocytosis—Dactinomycin—ocular cancer	0.00688	0.0165	CcSEcCtD
Trabectedin—Flushing—Dactinomycin—ocular cancer	0.00614	0.0147	CcSEcCtD
Trabectedin—Alopecia—Dactinomycin—ocular cancer	0.00585	0.014	CcSEcCtD
Trabectedin—Anaemia—Dactinomycin—ocular cancer	0.00532	0.0127	CcSEcCtD
Trabectedin—Leukopenia—Dactinomycin—ocular cancer	0.00516	0.0123	CcSEcCtD
Trabectedin—Myalgia—Dactinomycin—ocular cancer	0.0049	0.0117	CcSEcCtD
Trabectedin—Oedema—Dactinomycin—ocular cancer	0.0047	0.0113	CcSEcCtD
Trabectedin—Infection—Dactinomycin—ocular cancer	0.00467	0.0112	CcSEcCtD
Trabectedin—Thrombocytopenia—Dactinomycin—ocular cancer	0.0046	0.011	CcSEcCtD
Trabectedin—Anorexia—Dactinomycin—ocular cancer	0.00448	0.0107	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.00428	0.0103	CcSEcCtD
Trabectedin—Decreased appetite—Dactinomycin—ocular cancer	0.00409	0.00978	CcSEcCtD
Trabectedin—Fatigue—Dactinomycin—ocular cancer	0.00405	0.0097	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dactinomycin—ocular cancer	0.00384	0.0092	CcSEcCtD
Trabectedin—Body temperature increased—Dactinomycin—ocular cancer	0.00372	0.0089	CcSEcCtD
Trabectedin—Abdominal pain—Dactinomycin—ocular cancer	0.00372	0.0089	CcSEcCtD
Trabectedin—Hypersensitivity—Dactinomycin—ocular cancer	0.00346	0.00829	CcSEcCtD
Trabectedin—Asthenia—Dactinomycin—ocular cancer	0.00337	0.00807	CcSEcCtD
Trabectedin—Diarrhoea—Dactinomycin—ocular cancer	0.00322	0.0077	CcSEcCtD
Trabectedin—Vomiting—Dactinomycin—ocular cancer	0.00299	0.00715	CcSEcCtD
Trabectedin—Rash—Dactinomycin—ocular cancer	0.00296	0.0071	CcSEcCtD
Trabectedin—Nausea—Dactinomycin—ocular cancer	0.00279	0.00668	CcSEcCtD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—MYC—ocular cancer	0.00128	0.0022	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—MDM2—ocular cancer	0.00128	0.0022	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—CCND1—ocular cancer	0.00127	0.00218	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—EP300—ocular cancer	0.00125	0.00214	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—TP53—ocular cancer	0.00125	0.00214	CbGpPWpGaD
Trabectedin—SRC—Interleukin-11 Signaling Pathway—AKT1—ocular cancer	0.00124	0.00213	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.00123	0.00211	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—CDKN1B—ocular cancer	0.00119	0.00205	CbGpPWpGaD
Trabectedin—SRC—ErbB Signaling Pathway—HRAS—ocular cancer	0.00119	0.00205	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PSPH—ocular cancer	0.00118	0.00203	CbGpPWpGaD
Trabectedin—SRC—TSLP Signaling Pathway—AKT1—ocular cancer	0.00118	0.00202	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—EP300—ocular cancer	0.00117	0.00201	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—CDKN1B—ocular cancer	0.00117	0.002	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CCND3—ocular cancer	0.00116	0.002	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HDAC1—ocular cancer	0.00115	0.00198	CbGpPWpGaD
Trabectedin—SRC—IL-3 Signaling Pathway—AKT1—ocular cancer	0.00114	0.00196	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00113	0.00194	CbGpPWpGaD
Trabectedin—SRC—Kit receptor signaling pathway—HRAS—ocular cancer	0.00111	0.00191	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—CDKN1A—ocular cancer	0.0011	0.00189	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by PTP1B—AKT1—ocular cancer	0.00109	0.00187	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—CDKN1A—ocular cancer	0.00108	0.00185	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—TP53—ocular cancer	0.00108	0.00185	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00107	0.00183	CbGpPWpGaD
Trabectedin—SRC—Endothelins—HRAS—ocular cancer	0.00106	0.00181	CbGpPWpGaD
Trabectedin—SRC—FGF signaling pathway—AKT1—ocular cancer	0.00105	0.00181	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—TP53—ocular cancer	0.00105	0.0018	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—HRAS—ocular cancer	0.00104	0.00179	CbGpPWpGaD
Trabectedin—SRC—RANKL/RANK Signaling Pathway—AKT1—ocular cancer	0.00104	0.00178	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—HRAS—ocular cancer	0.00103	0.00177	CbGpPWpGaD
Trabectedin—SRC—Thromboxane A2 receptor signaling—AKT1—ocular cancer	0.00102	0.00176	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—HRAS—ocular cancer	0.00102	0.00175	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—MDM2—ocular cancer	0.00101	0.00173	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—HRAS—ocular cancer	0.001	0.00173	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—HRAS—ocular cancer	0.000993	0.00171	CbGpPWpGaD
Trabectedin—SRC—Kit receptor signaling pathway—AKT1—ocular cancer	0.000982	0.00169	CbGpPWpGaD
Trabectedin—SRC—CDC42 signaling events—HRAS—ocular cancer	0.00097	0.00167	CbGpPWpGaD
Trabectedin—SRC—Notch Signaling Pathway—AKT1—ocular cancer	0.000956	0.00164	CbGpPWpGaD
Trabectedin—SRC—Endothelins—AKT1—ocular cancer	0.000932	0.0016	CbGpPWpGaD
Trabectedin—SRC—Integrins in angiogenesis—AKT1—ocular cancer	0.000932	0.0016	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—CCND1—ocular cancer	0.000927	0.00159	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—CDKN1B—ocular cancer	0.000922	0.00158	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—AKT1—ocular cancer	0.00092	0.00158	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—HRAS—ocular cancer	0.000918	0.00158	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—AKT1—ocular cancer	0.000909	0.00156	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—MDM2—ocular cancer	0.000908	0.00156	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—MDM2—ocular cancer	0.000903	0.00155	CbGpPWpGaD
Trabectedin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000902	0.00155	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—MDM2—ocular cancer	0.000899	0.00154	CbGpPWpGaD
Trabectedin—SRC—AGE/RAGE pathway—AKT1—ocular cancer	0.000898	0.00154	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—AKT1—ocular cancer	0.000898	0.00154	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—CDKN1A—ocular cancer	0.000897	0.00154	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—ocular cancer	0.000894	0.00153	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TGFB1—ocular cancer	0.000891	0.00153	CbGpPWpGaD
Trabectedin—SRC—Disease—SAG—ocular cancer	0.000888	0.00153	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—AKT1—ocular cancer	0.000887	0.00152	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PSPH—ocular cancer	0.000882	0.00152	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—ocular cancer	0.000877	0.00151	CbGpPWpGaD
Trabectedin—SRC—Costimulation by the CD28 family—AKT1—ocular cancer	0.000877	0.00151	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—ocular cancer	0.000872	0.0015	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GNA11—ocular cancer	0.000872	0.0015	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—HRAS—ocular cancer	0.000855	0.00147	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—EP300—ocular cancer	0.000853	0.00147	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.000851	0.00146	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—MDM2—ocular cancer	0.000842	0.00145	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—MDM2—ocular cancer	0.000834	0.00143	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—CDKN1B—ocular cancer	0.000829	0.00142	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—MDM2—ocular cancer	0.000827	0.00142	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—CDKN1B—ocular cancer	0.000825	0.00142	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—MDM2—ocular cancer	0.000823	0.00141	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—CDKN1B—ocular cancer	0.000821	0.00141	CbGpPWpGaD
Trabectedin—SRC—Leptin signaling pathway—AKT1—ocular cancer	0.000811	0.00139	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—GNAQ—ocular cancer	0.00081	0.00139	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.000792	0.00136	CbGpPWpGaD
Trabectedin—SRC—Disease—E2F5—ocular cancer	0.000786	0.00135	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—MYC—ocular cancer	0.000777	0.00133	CbGpPWpGaD
Trabectedin—SRC—Disease—E2F4—ocular cancer	0.00077	0.00132	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—ocular cancer	0.00077	0.00132	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—CDKN1B—ocular cancer	0.000768	0.00132	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—HRAS—ocular cancer	0.000766	0.00132	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—CDKN1A—ocular cancer	0.000765	0.00131	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—CDKN1B—ocular cancer	0.000762	0.00131	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—CDKN1A—ocular cancer	0.000761	0.00131	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—CDKN1A—ocular cancer	0.000758	0.0013	CbGpPWpGaD
Trabectedin—SRC—Disease—RBL1—ocular cancer	0.000755	0.0013	CbGpPWpGaD
Trabectedin—SRC—Disease—RPL39—ocular cancer	0.000755	0.0013	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.000755	0.0013	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—AKT1—ocular cancer	0.000755	0.0013	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—CDKN1B—ocular cancer	0.000752	0.00129	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000745	0.00128	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—MYC—ocular cancer	0.000744	0.00128	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TGFB1—ocular cancer	0.000742	0.00127	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—AKT1—ocular cancer	0.00074	0.00127	CbGpPWpGaD
Trabectedin—SRC—Cell surface interactions at the vascular wall—HRAS—ocular cancer	0.000735	0.00126	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.000733	0.00126	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HDAC1—ocular cancer	0.000731	0.00125	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—HRAS—ocular cancer	0.000729	0.00125	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000723	0.00124	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.000709	0.00122	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—AKT1—ocular cancer	0.000707	0.00121	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—CDKN1A—ocular cancer	0.000703	0.00121	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—HRAS—ocular cancer	0.000701	0.0012	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.000701	0.0012	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.000697	0.0012	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—CDKN1A—ocular cancer	0.000694	0.00119	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—CCND1—ocular cancer	0.000693	0.00119	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.000691	0.00119	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00069	0.00118	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PSPH—ocular cancer	0.000681	0.00117	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000681	0.00117	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000667	0.00115	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—HRAS—ocular cancer	0.000652	0.00112	CbGpPWpGaD
Trabectedin—SRC—Integrin-mediated Cell Adhesion—AKT1—ocular cancer	0.000644	0.00111	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000635	0.00109	CbGpPWpGaD
Trabectedin—SRC—GAB1 signalosome—AKT1—ocular cancer	0.000634	0.00109	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000628	0.00108	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PSPH—ocular cancer	0.000626	0.00108	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SAG—ocular cancer	0.000622	0.00107	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PSPH—ocular cancer	0.000621	0.00107	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—AKT1—ocular cancer	0.000619	0.00106	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—ocular cancer	0.000611	0.00105	CbGpPWpGaD
Trabectedin—SRC—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.00061	0.00105	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.00061	0.00105	CbGpPWpGaD
Trabectedin—SRC—Disease—TFDP1—ocular cancer	0.000609	0.00105	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—AKT1—ocular cancer	0.000576	0.000989	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—MDM2—ocular cancer	0.000573	0.000985	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—HRAS—ocular cancer	0.000554	0.000951	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000553	0.00095	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000552	0.000948	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—E2F5—ocular cancer	0.000551	0.000946	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—HRAS—ocular cancer	0.000545	0.000936	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—E2F4—ocular cancer	0.000539	0.000926	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RBL1—ocular cancer	0.000529	0.000908	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CDKN1B—ocular cancer	0.000524	0.000899	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—CDK2—ocular cancer	0.000518	0.00089	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—AKT1—ocular cancer	0.000516	0.000886	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CDK4—ocular cancer	0.000499	0.000858	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—HRAS—ocular cancer	0.000498	0.000856	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—HRAS—ocular cancer	0.000496	0.000851	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000496	0.000851	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—HRAS—ocular cancer	0.000493	0.000847	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000491	0.000844	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—AKT1—ocular cancer	0.000489	0.00084	CbGpPWpGaD
Trabectedin—SRC—Disease—MAML2—ocular cancer	0.000484	0.000831	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—CDKN1A—ocular cancer	0.000483	0.00083	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—AKT1—ocular cancer	0.000481	0.000826	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—HRAS—ocular cancer	0.000462	0.000793	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—E2F3—ocular cancer	0.000459	0.000788	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—HRAS—ocular cancer	0.000458	0.000786	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000454	0.00078	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000454	0.000779	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—HRAS—ocular cancer	0.000452	0.000776	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—AKT1—ocular cancer	0.00044	0.000756	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—AKT1—ocular cancer	0.000438	0.000752	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000438	0.000752	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—HRAS—ocular cancer	0.000436	0.00075	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—AKT1—ocular cancer	0.000436	0.000748	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TFDP1—ocular cancer	0.000426	0.000732	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PSPH—ocular cancer	0.000409	0.000703	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000409	0.000703	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—AKT1—ocular cancer	0.000408	0.0007	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—AKT1—ocular cancer	0.000404	0.000694	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000401	0.000688	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—AKT1—ocular cancer	0.000399	0.000685	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—AKT1—ocular cancer	0.000385	0.000662	CbGpPWpGaD
Trabectedin—SRC—Membrane Trafficking—AKT1—ocular cancer	0.000385	0.000662	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000384	0.000659	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GNA11—ocular cancer	0.000372	0.000638	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000361	0.00062	CbGpPWpGaD
Trabectedin—SRC—Disease—HDAC1—ocular cancer	0.000354	0.000607	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—GNAQ—ocular cancer	0.000345	0.000593	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000341	0.000586	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAML2—ocular cancer	0.000339	0.000582	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—MDM2—ocular cancer	0.000327	0.000562	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN2B—ocular cancer	0.000317	0.000545	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—HRAS—ocular cancer	0.000315	0.00054	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—MDM2—ocular cancer	0.000314	0.000539	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1B—ocular cancer	0.000299	0.000513	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—EP300—ocular cancer	0.000297	0.00051	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNA11—ocular cancer	0.000296	0.000508	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—EP300—ocular cancer	0.000291	0.0005	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1B—ocular cancer	0.000287	0.000492	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—HRAS—ocular cancer	0.000285	0.000489	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000279	0.000479	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—AKT1—ocular cancer	0.000278	0.000477	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNA11—ocular cancer	0.000278	0.000477	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CDKN1A—ocular cancer	0.000276	0.000473	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—GNAQ—ocular cancer	0.000275	0.000472	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CDKN1A—ocular cancer	0.000265	0.000454	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—EP300—ocular cancer	0.000262	0.00045	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—GNAQ—ocular cancer	0.000258	0.000443	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TGFB1—ocular cancer	0.000258	0.000443	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TGFB1—ocular cancer	0.000253	0.000435	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HDAC1—ocular cancer	0.000248	0.000425	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN2B—ocular cancer	0.000222	0.000381	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNA11—ocular cancer	0.000214	0.000368	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—ocular cancer	0.000208	0.000358	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—E2F1—ocular cancer	0.000204	0.00035	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—HRAS—ocular cancer	0.000203	0.000349	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—HRAS—ocular cancer	0.000199	0.000342	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GNAQ—ocular cancer	0.000199	0.000342	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNA11—ocular cancer	0.000197	0.000338	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNA11—ocular cancer	0.000195	0.000336	CbGpPWpGaD
Trabectedin—SRC—Immune System—MDM2—ocular cancer	0.00019	0.000327	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000183	0.000315	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000182	0.000312	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—ocular cancer	0.000179	0.000308	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—ocular cancer	0.000179	0.000308	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—ocular cancer	0.000176	0.000302	CbGpPWpGaD
Trabectedin—SRC—Disease—MDM2—ocular cancer	0.000176	0.000302	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—ocular cancer	0.000174	0.000299	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—ocular cancer	0.000172	0.000296	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000161	0.000276	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—ocular cancer	0.000161	0.000276	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—ocular cancer	0.00016	0.000276	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—ocular cancer	0.000158	0.000272	CbGpPWpGaD
Trabectedin—SRC—Immune System—EP300—ocular cancer	0.000153	0.000262	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—ocular cancer	0.000152	0.000261	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—ocular cancer	0.000148	0.000255	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000147	0.000252	CbGpPWpGaD
Trabectedin—SRC—Disease—EP300—ocular cancer	0.000141	0.000242	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNA11—ocular cancer	0.000129	0.000221	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—EP300—ocular cancer	0.000124	0.000213	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MDM2—ocular cancer	0.000123	0.000212	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—ocular cancer	0.000123	0.000211	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—ocular cancer	0.000123	0.000211	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GNAQ—ocular cancer	0.00012	0.000206	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—ocular cancer	0.000112	0.000193	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—ocular cancer	0.000107	0.000184	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—ocular cancer	0.000105	0.00018	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—ocular cancer	0.000104	0.000178	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EP300—ocular cancer	9.87e-05	0.00017	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—ocular cancer	9.65e-05	0.000166	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—EP300—ocular cancer	9.28e-05	0.000159	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—ocular cancer	9.23e-05	0.000159	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—ocular cancer	8.6e-05	0.000148	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—ocular cancer	8.58e-05	0.000147	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—ocular cancer	8.52e-05	0.000146	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—ocular cancer	7.5e-05	0.000129	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—EP300—ocular cancer	7.16e-05	0.000123	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—ocular cancer	7.07e-05	0.000121	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—ocular cancer	6.76e-05	0.000116	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—EP300—ocular cancer	6.58e-05	0.000113	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—EP300—ocular cancer	6.53e-05	0.000112	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—ocular cancer	5.97e-05	0.000102	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—ocular cancer	5.61e-05	9.63e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—ocular cancer	4.33e-05	7.43e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—EP300—ocular cancer	4.3e-05	7.39e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—ocular cancer	3.98e-05	6.83e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—ocular cancer	3.94e-05	6.77e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—ocular cancer	2.6e-05	4.47e-05	CbGpPWpGaD
